Products containing mainly or only cannabidiol demonstrated almost no ability to manage a person's pain, a review of clinical ...

Products with THC reduced pain a little across multiple trials, but those that were mostly CBD didn't outperform placebos.

Cannabis products high in THC may provide short-term relief for chronic pain, while low-THC and CBD-only products show little ...

By Dennis Thompson HealthDay ReporterMONDAY, Dec. 29, 2025 (HealthDay News) — CBD and other cannabis derivatives are a bust ...

Short-term treatment with comparable and high tetrahydrocannabinol (THC)-to-cannabidiol (CBD) ratio cannabinoid products may improve pain and increase common adverse events, according to a review ...

Please provide your email address to receive an email when new articles are posted on . Patients receiving cannabidiol showed no patient-reported differences vs. a placebo group. The cannabidiol group ...

In patients with fibromyalgia, a 24-week treatment with a 50-mg/d dose of plant-derived cannabidiol did not outperform placebo in terms of pain relief or health-related quality of life. The only ...

Johnaé De Felicis is a health writer and passionate wellpreneur. Her mission in life is to inspire others to lead happy, healthy and wholesome lives, and she covers a variety of topics that are ...

Deb Hipp is a freelance health and medical writer and editor who lives in Kansas City, Missouri. She is a former investigative reporter with more than 25 years of experience as a journalist and writer ...

The global cannabidiol oil market size was US$ 3.57 billion in 2021. The global cannabidiol oil market is forecast to grow to US$ 16.3 billion by 2030 by registering a compound annual growth rate ...